Device offers relief from sneezing and runny nose

August 28, 2018 by Nancy Difiore, Rush University Medical Center
Credit: Rush University Medical Center

A new treatment that delivers a freezing or near-freezing temperature to the back of the nose can offer relief to people suffering from chronic stuffy or runny nose, postnasal drip and cough. These symptoms result from persistently inflamed nose and sinuses, a condition known as chronic rhinitis.

Called ClariFix, the treatment is a form of cryotherapy – the use of cold temperatures as a medical treatment—that targets out-of-balance nerves that result in chronic rhinitis. These faulty nerves tell the nose to drip, run and swell more than necessary.

The ClariFix device includes a small, chilled pad on a thin stem that is inserted through a nostril and applied to a targeted spot inside the nasal cavity. The freezing temperature interrupts the errant nerve signals, preventing them from triggering runny, stuffy noses. Specifically, ClariFix interrupts the neural pathway, a connection between parts of the nervous system that triggers rhinitis symptoms.

Rush University Medical Center ear, nose and throat specialists offer treatment to patients using ClariFix cryotherapy, which provides long-lasting relief and is the first and only FDA-cleared device for treating chronic rhinitis.

"Longstanding runny nose and congestion can slowly deprive patients of their quality of life. In the past, medications were the only option that could be offered to our patients. The introduction of ClariFix now offers the possibility of a more definitive solution that has the potential to offer long-lasting relief from rhinitis symptoms," said Dr. Pete Batra, professor and chairperson of the Department of Otorhinolaryngology-Head and Neck Surgery at Rush.

More than 24 million Americans suffer from the frustrating symptoms caused by chronic rhinitis.

Traditional medical treatments such as nasal sprays, drops and pills can help manage chronic rhinitis symptoms for some people, but often does not address the underlying problem and may have side effects.

ClariFix cryotherapy is a proven treatment option that can be performed in the office. After a numbing medication has been inserted into the patient's nose and left in place for 10 to 15 minutes, the patient receives the 30 second treatment on each side and can return to work after the procedure. The most common side effects associated with ClariFix cryotherapy are temporary increased congestion and transient pain or discomfort, which normally resolved or is mild after 1 to 2 days. Many patients rate pain as minor.

Clinical study results published in October showed that the treatment was well-tolerated with no device or procedure-related adverse events. After treatment, there was an improvement in runny nose and congestion symptoms and four out of five patients reported long-lasting symptom improvement. Results were similar in both allergic and non-allergic rhinitis patients.

Explore further: AAO-HNSF clinical practice guideline: Allergic rhinitis

Related Stories

AAO-HNSF clinical practice guideline: Allergic rhinitis

February 2, 2015
The American Academy of Otolaryngology—Head and Neck Surgery Foundation addresses quality improvement opportunities in the diagnosis and management of allergic rhinitis in a new multi-disciplinary, evidence-based clinical ...

State-of-the-science help for hay fever sufferers

February 2, 2015
Sublingual immunotherapy is one of several state-of-the-science treatments for allergic rhinitis, or "hay fever," being recommended by a panel of experts in a new guideline published Feb. 2, 2015, by the American Academy ...

Aspirin desensitization improves alcohol-induced allergies in patients with underlying respiratory disease

July 10, 2018
Patients who suffer from Aspirin Exacerbated Respiratory Disease (AERD) often experience an additional allergic reaction when drinking alcohol, including nasal congestion, wheezing, and a runny nose. Now a new study led by ...

Study finds Tianjiu therapy improves allergic rhinitis patients' daily life quality

June 13, 2017
The School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) recently conducted a "Tianjiu therapy for allergic rhinitis: A double-blinded randomised Placebo-controlled clinical trial". It found that Tianjiu ...

Many pick the wrong drugs for sneezin' season

March 30, 2018
(HealthDay)—Hay fever sufferers often choose the wrong medication for their seasonal sniffles, new research suggests.

Got the sniffles? Migraines spike with allergies and hay fever

November 25, 2013
People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according ...

Recommended for you

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

Polio: Environmental monitoring will be key as world reaches global eradication

October 15, 2018
Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, ...

Study traces hospital-acquired bloodstream infections to patients' own bodies

October 15, 2018
The most common source of a bloodstream infection acquired during a hospital stay is not a nurse's or doctor's dirty hands, or another patient's sneeze or visitor's cough, but the patient's own gut, Stanford University School ...

Researchers make essential imaging tests safer for people at risk of acute kidney injury

October 15, 2018
Every year, millions of people undergo medical tests and procedures, such as coronary angiography, which use intravascular contrast dyes. "For the majority of patients, these are safe and necessary procedures. However, about ...

Medical marijuana might help MS patients, but uncertainty remains

October 13, 2018
Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Do not give decongestants to young children for common cold symptoms, say experts

October 11, 2018
Decongestants should not be given to children under 6—and given with caution in children under 12—as there is no evidence that they alleviate symptoms such as a blocked or runny nose, and their safety is unclear, say ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.